M&A Deal Summary |
|
|---|---|
| Date | 2019-12-10 |
| Target | R&S Northeas |
| Sector | Medical Products |
| Buyer(s) | Amneal Pharmaceuticals |
| Deal Type | Add-on Acquisition |
| Deal Value | 340M USD |
| Advisor(s) | Raymond James - Investment Banking (Financial) Frost Brown Todd (Legal) |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 2002 |
| Sector | Healthcare Services |
| Employees | 8,300 |
| Revenue | 2.8B USD (2024) |
Amneal Pharmaceuticals manufactures and supplies generic pharmaceuticals. The company offers prescription pharmaceutical products in various forms, including oral solids that range from tablets to capsules and soft gels; and liquid-form pharmaceuticals that range from suspensions to solutions. Amneal Pharmaceuticals was founded in 2002 and is based in Bridgewater, New Jersey.
| DEAL STATS | # |
|---|---|
| Overall | 4 of 6 |
| Sector: Medical Products M&A | 1 of 1 |
| Type: Add-on Acquisition M&A Deals | 3 of 3 |
| State: Tennessee M&A | 1 of 1 |
| Country: United States M&A | 4 of 6 |
| Year: 2019 M&A | 1 of 1 |
| Size (of disclosed) | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2019-05-17 |
Amneal Deutschland
Gröbenzell, Germany Amneal Deutschland GmbH is a manufacturer and distributor of pharmaceuticals products. Amneal Deutschland GmbH is based in Gröbenzell, Germany. |
Sell | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-04-05 |
Kashiv Specialty Pharmaceuticals
Piscataway, New Jersey, United States Kashiv Specialty Pharmaceuticals is a developer of complex generics, innovative drug delivery platforms and novel 505(b)(2) drugs. Kashiv Specialty Pharmaceuticals is based in Piscataway, New Jersey. |
Buy | - |
